ConductScience.org, home
MUSK: muscle associated receptor tyrosine kinase
API referenceFor AI assistants

Gene · 4593

Papers3,141

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 3,141

Download this page as JSON
TitleJournalYearPMIDFound bySource
Apheresis-Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate-Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis.J Clin Apher202642817013PubTator, text miningPubMed
Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis.CNS Drugs202642814271PubTator, text miningPubMed
Very Late-Onset Myasthenia Gravis in a Very Elderly Patient: Diagnostic Challenges and Importance of Early Recognition.Geriatrics (Basel)202642776710PubTator, text miningPubMed
Crk/Crk-L-mediated Rapgef1 recruitment couples MuSK signaling to AChR anchoring at the neuromuscular junction.Cell Chem Biol202642772281PubTator, text miningPubMed
Digital assessment in myasthenia gravis: evidence, validation, and a proposed framework for autoimmune heterogeneity, remote monitoring, and clinical endpoints.Front Immunol202642756700PubTator, text miningPubMed
A case report of sequential efgartigimod and rituximab treatment for tSNMG.Front Immunol202642755762PubTator, text miningPubMed
[A differentiated approach to thymectomy in generalized form of myasthenia gravis].Khirurgiia (Mosk)202642735009PubTator, text miningPubMed
TUBA4A Pathogenic Variant Manifesting With Adulthood-Onset Genetic Myasthenic Syndrome, Myopathy, and Infertility.Eur J Neurol202642725680PubTator, text miningPubMed
Motor unit number index (MUNIX) in myasthenia gravis: A cross-sectional pilot sudy.J Electromyogr Kinesiol202642721533PubTator, text miningPubMed
Efgartigimod and Steroid Pulse Therapy as an Early Fast-acting Treatment Strategy for Anti-MUSK Myasthenic Crisis.Intern Med202642716742PubTator, text miningPubMed
The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.Front Immunol202642694599PubTator, text miningPubMed
MuSK myasthenia gravis: from antigen-antibody to clinical translation.Front Immunol202642582756PubTator, text miningPubMed
Accuracy of Antibody Testing in Myasthenia Gravis: The ADAM Study.Neurology202642579824PubTator, text miningPubMed
Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial: A Prespecified Analysis of a Randomized Clinical Trial.JAMA Neurol202642573995PubTator, text miningPubMed
Prospective study of efgartigimod in severe myasthenia gravis exacerbations requiring ventilatory or enteral support.J Neuromuscul Dis202642551446PubTator, text miningPubMed
Response to the comment on "Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis".J Neuroimmunol202642551221PubTator, text miningPubMed
Comment on "Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis".J Neuroimmunol202642546453PubTator, text miningPubMed
Identification of PTGS2 as a genetically supported protective biomarker and potential therapeutic target in myasthenia gravis.J Neuroimmunol202642541991PubTator, text miningPubMed
New-Onset Myasthenia Gravis Associated with SARS-CoV-2 Infection: A Systematic Review.Life (Basel)202642514170PubTator, text miningPubMed
LRP4-Related Congenital Myasthenic Syndrome: Clinical, Pathophysiological, and Therapeutic Aspects.Muscles202642496377PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4593/papers

API referenceFor AI assistants